Latest News
Use of Pectoral Nerve Blocks for Pacemaker or ICD Placement in Pediatric Patients
Long-Term Outcomes After PCI With New-Generation DES for P-LAD vs Non-P-LAD Lesions
Noninvasive Wearable Sensor Accurately Predicts HF Rehospitalization
ASHP: Critical Medications Needed for Ventilating Patients With COVID-19 in Short Supply
Predictors of Atrial Fibrillation in Patients With Transient Ischemic Attack
Two-Thirds of Patients Treated With Statins for ACS May Not to Achieve Recommended LDL-C Target
Obesity Found to Increase the Risk for Pulmonary Hypertension
Statin-Associated Risk for Intracerebral Hemorrhage in Patients With Prior Stroke
Apixaban May Be Safer Than Rivaroxaban for Atrial Fibrillation
Initial Invasive Strategy May Not Improve Outcomes in Stable Coronary Disease
The Role of the AHA in the COVID19 Pandemic
Irregular and Polymorphic Ventricular Arrhythmias More Frequent in Active vs Healed Myocarditis
Rivaroxaban Plus Aspirin Beneficial in Symptomatic PAD After Revascularization
Dapagliflozin CKD Trial Stopped Early Due to “Overwhelming Efficacy”
Latest Features
Combating COVID-19: Best Practices That Clinicians Need to Know
How should clinicians combat coronavirus disease (COVID-19) in their practice settings?
Assessing Cardiovascular Disease Risk in Rheumatoid Arthritis
The risk for cardiovascular disease is grossly underestimated and may account for the disproportionately high percentage of cardiovascular-related deaths in this population.
Reviewing Evidence on the Screening, Diagnosis, and Care of Familial Hypercholesterolemia
Familial hypercholesterolemia is one of the most clinically relevant monogenic disorders contributing to the development of atherosclerotic cardiovascular disease.
